Articles by Larijani B (7)

Evaluation of acute and sub-chronic toxicity of Semelil (ANGIPARS™), a new phytotherapeutic drug for wound healing in rodents

Abdollahi M, Farzamfar B, Salari P, Khorram Khorshid HR, Larijani B, Farhadi M and Madani SH

DARU 16 ( S1 ): 7 - 14 , 2008

Assessment of maximum tolerated dose of a new herbal drug, Semelil (ANGIPARS™) in patients with diabetic foot ulcer: A Phase I clinical trial

Heshmat R, Mohammad K, Mohajeri Tehrani MR, Tabatabaie Malazy O, Keshtkar AA, Gharibdoust F and Larijani B

DARU 16 ( S1 ): 25 - 30 , 2008

Effect of ANGIPARS™, a new herbal drug on diabetic foot ulcer: A phase 2 clinical study

Masoompour SM, Bagheri MH, Borhani Haghighi A, Novitsky YA, Sadeghi B, Gharibdoust F, Larijani B and Ranjbar Omrani G

DARU 16 ( S1 ): 31 - 34 , 2008

Effects of intravenous Semelil (ANGIPARS™) on diabetic foot ulcers healing: A multicenter clinical trial

Larijani B, Heshmat R, Bahrami A, Delshad H, Ranjbar Omrani G, Mohammad K, Heidarpour R, Mohajeri Tehrani MR, Kamali K, Farhadi M, Gharibdoust F and Madani SH

DARU 16 ( S1 ): 35 - 40 , 2008

Clinical application of oral form of ANGIPARS™ and in combination with topical form as a new treatment for diabetic foot ulcers: A randomized clinical trial

Bahrami A, Kamali K, Ali-Asgharzadeh A, Hosseini P, Heshmat R, Khorram Khorshid HR, Gharibdoust F, Madani SH and Larijani B

DARU 16 ( S1 ): 41 - 48 , 2008

Intravenous Semelil (ANGIPARS™) as a novel therapy for pressure Ulcers: A randomized clinical trial

Shamimi Nouri K, Heshmat R, Karimian R, Nasli E, Larijani B, Novitsky YA, Farhadi M and Gharibdoust F

DARU 16 ( S1 ): 49 - 53 , 2008

Topical application of Semelil (ANGIPARS™) in treatment of pressure ulcers: A randomized clinical trial

Shamimi Nouri K, Karimian R, Nasli E, Kamali K, Chaman R, Farhadi M, Madani SH, Larijani B and Khorram Khorshid HR

DARU 16 ( S1 ): 54 - 57 , 2008